Browse 161 schizophrenia clinical trials enrolling across the United States and Canada. 84 people applied to schizophrenia studies last month. Search by city or state to find one near you.
Filter
1
Filter results
Results: 161
Featured
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
for
Schizophrenia
Location: Marlton NJ, Gaithersburg MD, Little Rock AR,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07145918
Phase2, Recruiting
Active & Responsive
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
for
Schizophrenia
Location: Little Rock AR, Richardson TX
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 60
Code: NCT07680946
Phase2, Recruiting
Active & Responsive
Inter-Brain Synchrony in Schizophrenia
for
Schizophrenia Disorder
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18 - 65
Code: NCT07177261
Recruiting
Active & Responsive
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
for
Schizophrenia, Schizoaffective Disorder, Control Subjects
Location: Piscataway NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18 - 50
Code: NCT06745479
Recruiting
Active & Responsive
A Study to Evaluate the Effect of KarXT on Urological Safety
for
Schizophrenia
Location: Marlton NJ, Philadelphia PA, West Palm Beach FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT07221877
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Anti-Inflammatory Challenge in Schizophrenia
for
Schizophrenia
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18 - 55
Code: NCT05823532
Recruiting
Active & Responsive
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
for
Treatment-resistant Schizophrenia
Location: New York NY, Baltimore MD, Los Angeles CA
Sponsor: Newron Pharmaceuticals SPA
Sex: All
Age: 18+
Code: NCT07184619
Phase3, Recruiting
Active & Responsive
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
for
Major Depressive Disorder, Obsessive-Compulsive Disorder,
Location: Sunnyvale CA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18 - 65
Code: NCT06376734
Phase2, Recruiting
Active & Responsive
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
for
Schizophrenia
Location: Philadelphia PA, Wilmington NC, Cary NC, Miami FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07379827
Recruiting
Active & Responsive
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
for
Schizophrenia, Cannabis Use Disorder
Location: West Haven CT
Sponsor: Yale University
Sex: All
Age: 21 - 60
Code: NCT06058702
Phase1, Recruiting
Active & Responsive
52-week Open Label Safety-Tolerability Study
for
Schizophrenia
Location: New York NY, Philadelphia PA, Gaithersburg MD,